Leading national health research and innovation organizations in Canada have come together to form Research 7 (R7), a partnership to work with Canadian governments to tackle the biggest health and health care challenges in the country and secure its place as a global leader in health innovation.
The federal government’s science and technology strategy, the Council of Canadian Academies and the Science, Technology and Innovation Council (STIC) have identified Canada’s Health and Life Sciences sector as an engine for economic growth and long-term prosperity that can close the innovation gap with Canada’s traditional competitors and emerging economies.
The recent Jenkins’ report, Innovation Canada: A Call to Action, called for Canada to take “a fundamentally new approach to building public–private research collaborations in areas of strategic importance and opportunity for the economy.” The report also called for a “whole lot of government leadership.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze